Skip to main content
Premium Trial:

Request an Annual Quote

LI-COR Biosciences, BD Biosciences Market Infrared System for Pathway Analysis

NEW YORK, Jan. 29-LI-COR Biosciences and BD Biosciences will jointly market an infrared antibody-based imaging system for cell signaling pathway analysis, the two companies said today.


In the cooperative effort, BD's Pharmigen division will supply antibodies designed for use with LI-COR's Odyssey Infrared Imaging System.


BD Biosciences Pharmigen has a license to LI-COR's IRDye800CW, and will commercialize antibodies conjugated to this dye.


These two products will allow researchers interested in cell signaling to analyze more than one target molecule at a time. LI-COR says that its infrared imaging system can detect and quantify as little as one picogram of protein in Western blots.


LI-COR, which makes infrared labeling systems for sequencing, genotyping, and proteomics, is based in Lincoln, Neb. BD Biosciences is a  business division of Becton, Dickinson and Company.

For further information, see the press release.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.